Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae

Veterinary Microbiology

Volumn 154, Issue 1-2, 2011, Pages 49-57

  Feng, Hao ^a,b   Liang, Meng ^a,b   Wang, Hua lei ^b   Zhang, Tao ^c   Zhao, Ping sen ^d   Shen, Xing jia ^e   Zhang, Ren zhou ^b   Hu, Gui qiu ^b   Gao, Yu wei ^b   Wang, Cheng yu ^b   Wang, Tie cheng ^b   Zhang, Wei ^f   Yang, Song tao ^b   Xia, Xian zhu ^b  

^a JILIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c INSTITUTE OF ZOOLOGY   (China)

^d INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^e JIANGSU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^f DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Baculovirus; Chimeric virus like particles; CPV; RV; Silkworm pupae

Indexed keywords

EPITOPE; HYBRID PROTEIN; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS; BIOREACTOR; CELL STRUCTURE; CONTROLLED STUDY; FELINE PANLEUKOPENIA VIRUS; HEMAGGLUTINATION; IMMUNOREACTIVITY; NONHUMAN; PROTEIN EXPRESSION; PUPA (LIFE CYCLE STAGE); RABIES VIRUS; SILKWORM; T LYMPHOCYTE; VIRION; VIRUS CAPSID; VIRUS INFECTION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; BACULOVIRIDAE; BOMBYX; CAPSID PROTEINS; CELLS, CULTURED; DOGS; EPITOPES; GENETIC VECTORS; HEMAGGLUTINATION TESTS; PARVOVIRUS, CANINE; PUPA; RECOMBINANT FUSION PROTEINS;

BOMBYX MORI; CANINE PARVOVIRUS; MIRIDAE; RABIES VIRUS;

EID: 80655127806     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.06.022     Document Type: Article

References (30)

1. Appel M., Scott F., Carmichael L. Isolation and immunisation studies of a canine parco-like virus from dogs with haemorrhagic enteritis. Veterinary Record 1979, 105:156.
2. Barbis D., Chang S., Parrish C. Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding. Virology 1992, 191:301-308.
3. Burtonboy G., Coignoul F., Delferriere N., Pastoret P. Canine hemorrhagic enteritis: detection of viral particles by electron microscopy. Archives of Virology 1979, 61:1-11.
4. Chackerian B. Virus-like particles: flexible platforms for vaccine development. Expert Review of Vaccines 2007, 6:381-390.
5. Chandran D., Shahana P., Rani G., Sugumar P., Shankar C., Srinivasan V. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper. Vaccine 2009, 28:132-139.
6. Chang S., Sgro J., Parrish C. Multiple amino acids in the capsid structure of canine parvovirus coordinately determine the canine host range and specific antigenic and hemagglutination properties. Journal of Virology 1992, 66:6858.
7. Cox J., Dietzschold B., Schneider L. Rabies virus glycoprotein. II. Biological and serological characterization. Infection and Immunity 1977, 16:754.
8. Dietzschold B., Gore M., Marchadier D., Niu H., Bunschoten H., Otvos L., Wunner W., Ertl H., Osterhaus A., Koprowski H. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 1990, 64:3804.
9. Du D., Nabi K., Suzuki A., Park F.E. Expression of functional human (pro) renin receptor in silkworm (larvae) using BmNPV bacmid. Biotechnology and Applied Biochemistry 2008, 49:195-202.
10. Hurtado A., Rueda P., Nowicky J., Sarraseca J., Casal J. Identification of domains in canine parvovirus VP2 essential for the assembly of virus-like particles. Journal of Virology 1996, 70:5422.
11. Jennings G., Bachmann M. Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines. Current Molecular Medicine 2007, 7:143-155.
12. Kamita S., Maeda S. Expression of foreign genes in Bombyx mori larvae using baculovirus vectors. Mehods in Molecular Biology 1995, 39:243-264.
13. Kato T., Kajikawa M., Maenaka K., Park E. Silkworm expression system as a platform technology in life science. Applied Microbiology and Biotechnology 2010, 85:459-470.
14. Kawana K., Yasugi T., Taketani Y. Human papillomavirus vaccines: current issues & future. The Indian Journal of Medical Research 2009, 130:341-347.
15. Langeveld J., Casal J., Vela C., Dalsgaard K., Smale S., Puijk W., Meloen R. B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. Journal of Virology 1993, 67:765.
16. Leona G., Jouni T., Outi V., Taija S., Eila K., Matti V., Christian O. Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles. Journal of Nanobiotechnology 2006, 4.
17. Luckow V. Baculovirus systems for the expression of human gene products. Current Opinion in Biotechnology 1993, 4:564-572.
18. Ramqvist T., Andreasson K., Dalianis T. Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opinion on Biological Therapy 2007, 7:997-1007.
19. Reed A., Jones E., Miller T. Nucleotide sequence and genome organization of canine parvovirus. Journal of Virology 1988, 62:266.
20. Reis U., Blum B., von Specht B., Domdey H., Collins J. Antibody production in silkworm cells and silkworm larvae infected with a dual recombinant Bombyx mori nuclear polyhedrosis virus. Nature Biotechnology 1992, 10:910-912.
21. Rueda P., Martínez-Torrecuadrada J., Sarraseca J., Sedlik C., del Barrio M., Hurtado A., Leclerc C., Casal J. Engineering parvovirus-like particles for the induction of B-cell, CD4+ and CTL responses. Vaccine 1999, 18:325-332.
22. Sedlik C., Dadaglio G., Saron M., Deriaud E., Rojas M., Casal S., Leclerc C. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. Journal of Virology 2000, 74:5769.
23. Sedlik C., Dridi A., Deriaud E., Saron M., Rueda P., Sarraseca J., Casal J., Leclerc C. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses. Journal of Virology 1999, 73:2739.
24. Sedlik C., Saron M., Sarraseca J., Casal I., Leclerc C. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:7503.
25. Singh P., Destito G., Schneemann A., Manchester M. Canine parvovirus-like particles, a novel nanomaterial for tumor targeting. Journal of Nanobiotechnology 2006, 4.
26. Spohn G., Bachmann M. Exploiting viral properties for the rational design of modern vaccines. Expert Review of Vaccines 2008, 7:43-54.
27. Tsao J., Chapman M., Agbandje M., Keller W., Smith K., Wu H., Luo M., Smith T., Rossmann M., Compans R. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991, 251:1456.
28. van der Heijden R., Langedijk J., Groen J., UytdeHaag F., Meloen R., Osterhaus A. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein. Journal of General Virology 1993, 74:1539.
29. Varsani A., Williamson A., De Villiers D., Becker I., Christensen N., Rybicki E. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16. Journal of Virology 2003, 77:8386.
30. Woo W., Doan T., Herd K., Netter H., Tindle R. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes. Journal of Virology 2006, 80:3975.